title: Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
authors.forename: D
authors.initials: D
authors.lastname: Reinhardt
authors.forename: S
authors.initials: S
authors.lastname: Diekamp
authors.forename: C
authors.initials: C
authors.lastname: Langebrake
authors.forename: J
authors.initials: J
authors.lastname: Ritter
authors.forename: J
authors.initials: J
authors.lastname: Stary
authors.forename: M
authors.initials: M
authors.lastname: Dworzak
authors.forename: A
authors.initials: A
authors.lastname: Schrauder
authors.forename: M
authors.initials: M
authors.lastname: Zimmermann
authors.forename: G
authors.initials: G
authors.lastname: Fleischhack
authors.forename: W-D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: J
authors.initials: J
authors.lastname: Harbott
authors.forename: U
authors.initials: U
authors.lastname: Creutzig
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D007223:Infant; D007947:Leukemia, Megakaryoblastic, Acute / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D012074:Remission Induction / Q000379:methods; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D003561:Cytarabine; D005047:Etoposide; D015255:Idarubicin